Company Name: Sangamo BioSciences, Inc.

Sangamo BioSciences, Inc. is a clinical stage biopharmaceutical company. The company is engaged in the development of engineered zinc finger DNA-binding proteins and is developing therapeutics for monogenic and infectious diseases using its proprietary ZFP technology platform.

Ticker Symbol: SGMO (NASDAQ)

Company Website: www.sangamo.com

Social Media: Sangamo BioSciences LinkedIn

Headquarters: Richmond, CA